These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9821952)

  • 21. Constitutive expression of the interferon-inducible protein p202 in NIH 3T3 cells affects cell cycle progression.
    Lembo D; Angeretti A; Benefazio S; Hertel L; Gariglio M; Novelli F; Landolfo S
    J Biol Regul Homeost Agents; 1995; 9(2):42-6. PubMed ID: 9127631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha.
    Geng Y; Choubey D
    J Biol Regul Homeost Agents; 2000; 14(4):263-8. PubMed ID: 11215814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.
    Hurford RK; Cobrinik D; Lee MH; Dyson N
    Genes Dev; 1997 Jun; 11(11):1447-63. PubMed ID: 9192872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16.
    Johnstone RW; Wei W; Greenway A; Trapani JA
    Oncogene; 2000 Dec; 19(52):6033-42. PubMed ID: 11146555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antitumor activity by probasin promoter-directed p202 expression.
    Wen Y; Giri D; Yan DH; Spohn B; Zinner RG; Xia W; Thompson TC; Matusik RJ; Hung MC
    Mol Carcinog; 2003 Jul; 37(3):130-7. PubMed ID: 12884364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer.
    Ding Y; Wen Y; Spohn B; Wang L; Xia W; Kwong KY; Shao R; Li Z; Hortobagyi GN; Hung MC; Yan DH
    Clin Cancer Res; 2002 Oct; 8(10):3290-7. PubMed ID: 12374701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of an E2F-p130 complex formed during growth arrest.
    Corbeil HB; Branton PE
    Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
    Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells.
    Wen Y; Yan DH; Spohn B; Deng J; Lin SY; Hung MC
    Cancer Res; 2000 Jan; 60(1):42-6. PubMed ID: 10646849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
    Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA
    Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models.
    Wen Y; Yan DH; Wang B; Spohn B; Ding Y; Shao R; Zou Y; Xie K; Hung MC
    Cancer Res; 2001 Oct; 61(19):7142-7. PubMed ID: 11585747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
    Stiegler P; De Luca A; Bagella L; Giordano A
    Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202.
    Yan DH; Wen Y; Spohn B; Choubey D; Gutterman JU; Hung MC
    Oncogene; 1999 Jan; 18(3):807-11. PubMed ID: 9989832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
    Rampalli AM; Gao CY; Chauthaiwale VM; Zelenka PS
    Oncogene; 1998 Jan; 16(3):399-408. PubMed ID: 9467965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
    Helt AM; Galloway DA
    J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-inducible p202 in the susceptibility to systemic lupus.
    Choubey D; Kotzin BL
    Front Biosci; 2002 May; 7():e252-62. PubMed ID: 11991834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis.
    Xin H; D'Souza S; Jørgensen TN; Vaughan AT; Lengyel P; Kotzin BL; Choubey D
    J Immunol; 2006 May; 176(10):5863-70. PubMed ID: 16670293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.